BACKGROUND Literature reports an incidence of Surgical Site Infections (SSI) in oncological patients undergoing prosthetic replacement, between 8% and 35% after implantation and 43% after revision. The frequency of SSI has gradually decreased after the introduction of antibiotic prophylaxis, however the appropriateness of perioperative prophylaxis for these patients is still controversial. The purpose of this retrospective study, conducted at the oncologic orthopedic Unit of G.Pini Institute in Milan, was to evaluate: • the number of SSI in oncological megaprosthetic reconstruction between 2009 and 2011, • possible risk factors associated to the onset of SSI, • the antibiotic prophylaxis applied. METHODS We reviewed medical records of patients who underwent clean megaprosthetic reconstruction and collected hospitalization and follow up data, focusing on possible risk factors implied in the onset of SSI: patient characteristics, duration of surgery, number of persons in the operating room, size of resection, blood losses, antibiotic prophylaxis, etc. We registered every SSI meeting the criteria set by the European protocol HELICS. PRELIMINARY RESULTS 86 surgeries were evaluated, 37 women (43%) and 49 men (67%) whose mean age was 48 years and mostly ASA 2 (43%) and 3 (39%). Administration of prophylaxis was usually recorded (95%) and continued postoperatively (96%) for an average of 8 days, often related to the length of postsurgical stay. Mean duration of surgery was 256 minutes with a mean of 7 persons attending the operating room. We recorded 6 SSI on 86 surgeries evaluated (7%): 4 deep and 2 superficial, 4 occurring after one month and 2 after one year from surgery. Statistical analysis will be completed by integrating data from year 2008, whose? collection is in progress. CONCLUSIONS The criteria for inclusion or exclusion set in this study ,SSI definition and data collection forms, could be used in a prospective surveillance program, to be planned having made sure to be able to implement a follow up. Afterwards, the protocol could be improved and proposed for adoption in a prospective multicenter surveillance system.

Risk of infection in oncological megaprosthetic reconstruction / P. Daolio, R. Zorzi, S. Bastoni, A. Maione, S. Bronzin, P. Navone, M. Nobile, F. Auxilia. ((Intervento presentato al 26. convegno European Muscoloskeletal Oncology Society Meeting tenutosi a Goteborg nel 2013.

Risk of infection in oncological megaprosthetic reconstruction

S. Bastoni;A. Maione;S. Bronzin;M. Nobile
Penultimo
;
F. Auxilia
Ultimo
2013

Abstract

BACKGROUND Literature reports an incidence of Surgical Site Infections (SSI) in oncological patients undergoing prosthetic replacement, between 8% and 35% after implantation and 43% after revision. The frequency of SSI has gradually decreased after the introduction of antibiotic prophylaxis, however the appropriateness of perioperative prophylaxis for these patients is still controversial. The purpose of this retrospective study, conducted at the oncologic orthopedic Unit of G.Pini Institute in Milan, was to evaluate: • the number of SSI in oncological megaprosthetic reconstruction between 2009 and 2011, • possible risk factors associated to the onset of SSI, • the antibiotic prophylaxis applied. METHODS We reviewed medical records of patients who underwent clean megaprosthetic reconstruction and collected hospitalization and follow up data, focusing on possible risk factors implied in the onset of SSI: patient characteristics, duration of surgery, number of persons in the operating room, size of resection, blood losses, antibiotic prophylaxis, etc. We registered every SSI meeting the criteria set by the European protocol HELICS. PRELIMINARY RESULTS 86 surgeries were evaluated, 37 women (43%) and 49 men (67%) whose mean age was 48 years and mostly ASA 2 (43%) and 3 (39%). Administration of prophylaxis was usually recorded (95%) and continued postoperatively (96%) for an average of 8 days, often related to the length of postsurgical stay. Mean duration of surgery was 256 minutes with a mean of 7 persons attending the operating room. We recorded 6 SSI on 86 surgeries evaluated (7%): 4 deep and 2 superficial, 4 occurring after one month and 2 after one year from surgery. Statistical analysis will be completed by integrating data from year 2008, whose? collection is in progress. CONCLUSIONS The criteria for inclusion or exclusion set in this study ,SSI definition and data collection forms, could be used in a prospective surveillance program, to be planned having made sure to be able to implement a follow up. Afterwards, the protocol could be improved and proposed for adoption in a prospective multicenter surveillance system.
mag-2013
Settore MED/33 - Malattie Apparato Locomotore
Settore MED/42 - Igiene Generale e Applicata
Risk of infection in oncological megaprosthetic reconstruction / P. Daolio, R. Zorzi, S. Bastoni, A. Maione, S. Bronzin, P. Navone, M. Nobile, F. Auxilia. ((Intervento presentato al 26. convegno European Muscoloskeletal Oncology Society Meeting tenutosi a Goteborg nel 2013.
Conference Object
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/225154
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact